Skip to main content
New victory in HIV fight ‘shows more resources needed’

LABOUR MP Lloyd Russell-Moyle called for greater resources for HIV patients yesterday after a man in Britain became the second adult ever to be cleared of the disease.

The unnamed man received bone marrow stem cells from a donor with a mutation known as CCR5 delta 32, a rare anomaly that made the donor unusually resistant to HIV.

He has now been in remission for 18 months after his anti-retroviral drugs were discontinued in 2017, doctors at Hammersmith Hospital in west London said.

Ravinda Gupta, who led doctors treating the patient, said: “There is no virus that we can measure — we can’t detect anything.”

The patient is known as the “London patient,” in reference to Timothy Brown, the “Berlin patient” who became the first person to have been cleared of HIV in 2007.

About 37 million people worldwide are infected with HIV and Aids, and about 35 million people have been killed from the disease since the 1980s.

Mr Russell-Moyle, who became the first person to announce in the Commons that he is HIV positive in November last year, told the Star: “This shows that we are in the grasp of getting a cure.

“The case builds on the Berlin patient, and shows whilst the procedure itself is not a cure that the theory is in practice possible.

“It shows that more resources are needed to turn this experimental and dangerous treatment into a safe reality.”

Dr Michael Brady, medical director at HIV charity Terrence Higgins Trust, said: “Today’s news is a welcome development for many people living with HIV, but we must not take our eye off the ball in ensuring we use the tools we already have that can help us towards zero new transmissions.”

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
More from this author
Britain / 27 February 2020
27 February 2020
Britain / 27 February 2020
27 February 2020
Britain / 26 February 2020
26 February 2020
Similar stories
LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, Cal
Science and Society / 18 December 2024
18 December 2024
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
An electron micrograph of HIV-1 virus particles (colourized
Features / 13 September 2024
13 September 2024
ALAN ROSSI SILVA argues that Gilead’s HIV prevention drug, while promising, highlights systemic failures in the pharmaceutical industry, showing the need to shift towards state-owned drug development and production
Victims and campaigners outside Central Hall in Westminster,
Features / 5 June 2024
5 June 2024
In a tragedy of medical arrogance and corporate greed, 3,000 people, including 500 children, died from infected blood — then their relatives faced evasions and cover-ups instead of justice and compensation, writes MICHAEL MORRISSEY